Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCT

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02728700
Recruitment Status : Terminated (Accrual factor)
First Posted : April 5, 2016
Last Update Posted : September 12, 2018
Sponsor:
Information provided by (Responsible Party):
Stanford University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : April 2017
Actual Study Completion Date : July 2018